Samsara-Biocapital
AI_NATIVE detailed information: This accession holds the following tickers:[ "ABVX", "PRME", "AVDL", "SLRN", "TNGX", "TERN", "LENZ", "MLYS", "NGNE", "ALMS", "ALLK", "ARTV", "BOLT", "CTNM", "SRRK", "LPTX", "NKTX", "PVLA", "OKUR", "SEPN", "SRZN", "STRO", null, null, "ZYME", "UPB", "LYRA", "RYTM", "ACLX", "GOSS", "CRIS", "HLVX", "INZY", "KLRS", "KRON", "VTVT", "CRGX" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 37
- Total Value
- 560807077
- Accession Number
- 0001415889-25-013106
- Form Type
- 13F-HR
- Manager Name
- Samsara-Biocapital
Data Enrichment
95% identified35 identified2 unidentified
Holdings
37 positions • $560.8M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Shares:291.7K
Value:$875.0K
% of Portfolio:0.2% ($875.0K/$560.8M)
Shares:630.0K
Value:$863.1K
% of Portfolio:0.2% ($863.1K/$560.8M)
Shares:202.3K
Value:$558.5K
% of Portfolio:0.1% ($558.5K/$560.8M)
Shares:1.0M
Value:$419.7K
% of Portfolio:0.1% ($419.7K/$560.8M)
67080N119
Shares:133.3K
Value:$42.7K
% of Portfolio:0.0% ($42.7K/$560.8M)
86889P117
Shares:100.0K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$560.8M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
---|---|---|---|---|---|---|
241.4K | QoQ NEW(+241.4K) YoY NEW(+241.4K) | All Managers (Combined) | $2.8M | 0.5% ($2.8M/$560.8M) | QoQ NEW(+$2.8M) YoY NEW(+$2.8M) | |
Abivax S.A.(ABVXcusip00370M103) | 425.0K | All Managers (Combined) | $2.7M | 0.5% ($2.7M/$560.8M) | ||
2.2M | All Managers (Combined) | $1.4M | 0.3% ($1.4M/$560.8M) | |||
1.6M | All Managers (Combined) | $1.4M | 0.3% ($1.4M/$560.8M) | |||
291.7K | QoQ 0.00% (-0)YoY NEW(+291.7K) | All Managers (Combined) | $875.0K | 0.2% ($875.0K/$560.8M) | YoY NEW(+$875.0K) | |
630.0K | All Managers (Combined) | $863.1K | 0.2% ($863.1K/$560.8M) | |||
405.2K | All Managers (Combined) | $806.4K | 0.1% ($806.4K/$560.8M) | |||
2.4M | QoQ 0.00% (-0) | All Managers (Combined) | $745.2K | 0.1% ($745.2K/$560.8M) | ||
HilleVax, Inc.(HLVXcusip43157M102) | 399.6K | All Managers (Combined) | $579.5K | 0.1% ($579.5K/$560.8M) | ||
202.3K | All Managers (Combined) | $558.5K | 0.1% ($558.5K/$560.8M) | |||
1.0M | All Managers (Combined) | $419.7K | 0.1% ($419.7K/$560.8M) | |||
185.9K | YoY NEW(+185.9K) | All Managers (Combined) | $390.5K | 0.1% ($390.5K/$560.8M) | YoY NEW(+$390.5K) | |
1.4M | All Managers (Combined) | $175.6K | 0.0% ($175.6K/$560.8M) | |||
78.1K | All Managers (Combined) | $64.5K | 0.0% ($64.5K/$560.8M) | |||
(cusip67080N119)✕ | 133.3K | All Managers (Combined) | $42.7K | 0.0% ($42.7K/$560.8M) | ||
Allakos Inc.(ALLKcusip01671P100) | 172.1K | All Managers (Combined) | $39.2K | 0.0% ($39.2K/$560.8M) | ||
(cusip86889P117)✕ | 100.0K | All Managers (Combined) | $3.0K | 0.0% ($3.0K/$560.8M) |